Prince Charles and Camilla have received their first dose of the COVID-19 vaccine

• Prince Charles and Camilla got their first dose of the COVID-19 vaccine, Clarence House confirmed.
• The couple are in one of the UK's vaccination priority groups due to their age.
• The Prince of Wales tested positive for coronavirus back in March and experienced "mild symptoms."

Prince Charles and Camilla have received their first dose of the COVID-19 vaccine.

A Clarence House representative confirmed the news to Insider, although it is currently not known which vaccine the pair received or where they were administered.

Due to their age, the Prince of Wales, 72, and Duchess of Cornwall, 73, are part of the UK's fourth priority group who will be offered a vaccine by February 15.

Prince Charles tested positive for coronavirus during the first wave in March 2020 and experienced "mild symptoms," while Camilla tested negative.

Prince Charles previously expressed his confidence in the vaccination program. In a recent interview with CNN to discuss his environmental initiative, Terra Carta, he said: "I think vaccination is critical to ensure we have a way out of this, otherwise it is going to be very difficult."

The pair also visited Gloucestershire Royal Hospital back in December to meet key workers who are making the vaccination rollout possible.

When asked by CNN if he would accept a vaccine when it was offered to him, Charles confirmed that he "absolutely" would, but during his earlier visit to the hospital noted that he was "way down the list and will have to wait."

He and Camilla now join the Queen and Prince Phillip, who received their vaccines from a Royal Household doctor at Winsdor Castle in January.

The news was confirmed by a royal source, who said: "To prevent inaccuracies and further speculation, Her Majesty decided that she would let it be known she has had the vaccination."

The Queen's decision to make this private matter publicly known was seen as a bid to alleviate public anxiety about the vaccines. It is hoped that this visibility will encourage uptake in the number of people in the UK having vaccines, which is currently over 12 million people.